GlaxoSmithKline and Developing Country Access to Essential Medicines (B)

N. Craig Smith; Anne Duncan

SFDDSF

VOLUME 2

CONTACT

ABOUT

PRIVACY

NeilsonJournals Publishing

The Americas + Rest of World

Minimum Order Value
6 copies:

USD
$
19.80

Per Copy:

3.30

Europe

Minimum Order Value
6 copies:

EURO
€
28.80

Per Copy:

4.80

GB & NI

Minimum Order Value
6 copies:

GBP
£
19.80

Per Copy:

3.30

GlaxoSmithKline and Access to Essential Medicines (B)

N. Craig Smith and Anne Duncan
London Business School, UK

Volume 2 Issue 1: 2005, pp. 123-132; ABSTRACT

The (B) case summarizes GSK’s response to pressures to increase access to essential medicines in developing countries and subsequent developments.

ARTICLE REF.: JBEE2-1CS2